Famotidine and Ranitidine Control of 24 H Intragastric Acidity After Single Bedtime Administration: a Study Using Continuous PH Monitoring
Overview
Overview
Authors
Affiliations
Affiliations
Soon will be listed here.
Citing Articles
Pharmacokinetics of ranitidine in patients undergoing haemofiltration.
Gladziwa U, Krishna D, Klotz U, Ittel T, Schunkert H, Glockner W Eur J Clin Pharmacol. 1988; 35(4):427-30.
PMID: 3197752 DOI: 10.1007/BF00561377.
Savarino V, Mela G, Scalabrini P, Fera G, Zentilin P, Sumberaz A Eur J Clin Pharmacol. 1988; 35(2):203-7.
PMID: 3191940 DOI: 10.1007/BF00609254.
Savarino V, Scalabrini P, Mela G, Di Timoteo E, Percario G, Magnolia M Dig Dis Sci. 1988; 33(3):293-7.
PMID: 3125025 DOI: 10.1007/BF01535752.
References
1.
Vallot T, Mignon M, Mazure R, Bonfils S
. Evaluation of antisecretory drug therapy of Zollinger-Ellison syndrome (ZES) using 24-hour pH monitoring. Dig Dis Sci. 1983; 28(7):577-84.
DOI: 10.1007/BF01299916.
View
2.
Smith J
. Clinical pharmacology of famotidine. Digestion. 1985; 32 Suppl 1:15-23.
DOI: 10.1159/000199257.
View
3.
Fimmel C, Etienne A, Cilluffo T, von Ritter C, Gasser T, Rey J
. Long-term ambulatory gastric pH monitoring: validation of a new method and effect of H2-antagonists. Gastroenterology. 1985; 88(6):1842-51.
DOI: 10.1016/0016-5085(85)90009-5.
View